 Allison Blackmer
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parenteral Nutrition | 9 | 2023 | 95 | 2.020 |
Why?
| | Education, Pharmacy | 5 | 2018 | 121 | 1.850 |
Why?
| | Faculty, Pharmacy | 4 | 2017 | 16 | 1.450 |
Why?
| | Schools, Pharmacy | 4 | 2017 | 48 | 1.430 |
Why?
| | Career Mobility | 4 | 2017 | 61 | 1.400 |
Why?
| | Fat Emulsions, Intravenous | 3 | 2015 | 27 | 1.380 |
Why?
| | Pharmacists | 5 | 2017 | 231 | 1.320 |
Why?
| | Career Choice | 4 | 2017 | 177 | 1.270 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 111 | 1.130 |
Why?
| | Malnutrition | 5 | 2023 | 62 | 0.780 |
Why?
| | Cannabidiol | 2 | 2022 | 60 | 0.770 |
Why?
| | Nervous System Diseases | 2 | 2021 | 251 | 0.750 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 712 | 0.740 |
Why?
| | Clostridium Infections | 1 | 2021 | 53 | 0.720 |
Why?
| | Cholestasis | 2 | 2014 | 227 | 0.710 |
Why?
| | Motor Disorders | 1 | 2020 | 16 | 0.700 |
Why?
| | Muscle Spasticity | 1 | 2020 | 53 | 0.670 |
Why?
| | Cerebral Palsy | 1 | 2020 | 80 | 0.630 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2019 | 16 | 0.620 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 54 | 0.620 |
Why?
| | Disabled Persons | 1 | 2020 | 128 | 0.620 |
Why?
| | Parenteral Nutrition Solutions | 2 | 2015 | 2 | 0.590 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 114 | 0.570 |
Why?
| | Professional Competence | 1 | 2017 | 84 | 0.550 |
Why?
| | Educational Measurement | 1 | 2018 | 225 | 0.550 |
Why?
| | Teaching | 1 | 2018 | 197 | 0.540 |
Why?
| | Medication Adherence | 1 | 2021 | 530 | 0.540 |
Why?
| | Chronic Disease | 2 | 2021 | 1570 | 0.530 |
Why?
| | Enteral Nutrition | 5 | 2023 | 157 | 0.520 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 223 | 0.520 |
Why?
| | Selenium | 1 | 2015 | 31 | 0.480 |
Why?
| | Trace Elements | 1 | 2015 | 45 | 0.470 |
Why?
| | Empyema, Pleural | 1 | 2014 | 11 | 0.440 |
Why?
| | Pleural Effusion | 1 | 2014 | 46 | 0.430 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 62 | 0.420 |
Why?
| | Central Nervous System | 1 | 2014 | 229 | 0.410 |
Why?
| | Pediatrics | 4 | 2021 | 981 | 0.400 |
Why?
| | Tissue Plasminogen Activator | 1 | 2014 | 204 | 0.390 |
Why?
| | Copper | 1 | 2012 | 99 | 0.390 |
Why?
| | Cross Infection | 1 | 2013 | 195 | 0.380 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 230 | 0.370 |
Why?
| | Child | 12 | 2023 | 18340 | 0.360 |
Why?
| | Laxatives | 1 | 2010 | 17 | 0.360 |
Why?
| | Dietary Fiber | 1 | 2010 | 40 | 0.350 |
Why?
| | Humans | 34 | 2023 | 113531 | 0.340 |
Why?
| | Hospitalization | 2 | 2021 | 1765 | 0.340 |
Why?
| | Constipation | 1 | 2010 | 75 | 0.340 |
Why?
| | Polysaccharides | 1 | 2009 | 77 | 0.320 |
Why?
| | Pneumonia | 1 | 2014 | 561 | 0.310 |
Why?
| | Thrombocytopenia | 1 | 2009 | 175 | 0.290 |
Why?
| | Students, Pharmacy | 2 | 2018 | 97 | 0.280 |
Why?
| | Child, Preschool | 6 | 2021 | 9093 | 0.280 |
Why?
| | Infant | 6 | 2021 | 7922 | 0.270 |
Why?
| | Professional Role | 2 | 2017 | 148 | 0.260 |
Why?
| | Nutritional Support | 4 | 2022 | 27 | 0.260 |
Why?
| | Anticoagulants | 1 | 2009 | 548 | 0.240 |
Why?
| | Nutrition Disorders | 1 | 2023 | 22 | 0.220 |
Why?
| | Food, Formulated | 1 | 2023 | 14 | 0.220 |
Why?
| | Dietetics | 1 | 2023 | 22 | 0.210 |
Why?
| | Infant, Newborn | 4 | 2015 | 5032 | 0.210 |
Why?
| | Epilepsies, Myoclonic | 1 | 2022 | 41 | 0.190 |
Why?
| | Nutrition Therapy | 1 | 2022 | 30 | 0.190 |
Why?
| | Pharmaceutical Services | 1 | 2022 | 76 | 0.190 |
Why?
| | Public-Private Sector Partnerships | 1 | 2021 | 43 | 0.190 |
Why?
| | United States | 9 | 2023 | 12137 | 0.180 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 11 | 0.180 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 53 | 0.180 |
Why?
| | Vancomycin | 1 | 2021 | 73 | 0.180 |
Why?
| | Medication Therapy Management | 1 | 2020 | 67 | 0.170 |
Why?
| | Symptom Assessment | 1 | 2020 | 119 | 0.170 |
Why?
| | Analgesics | 1 | 2020 | 156 | 0.160 |
Why?
| | Health Personnel | 2 | 2023 | 569 | 0.160 |
Why?
| | Preceptorship | 1 | 2018 | 62 | 0.150 |
Why?
| | Employee Performance Appraisal | 1 | 2017 | 6 | 0.150 |
Why?
| | Faculty | 1 | 2018 | 123 | 0.140 |
Why?
| | Male | 7 | 2021 | 55112 | 0.140 |
Why?
| | Feedback | 1 | 2017 | 141 | 0.140 |
Why?
| | Female | 7 | 2021 | 59115 | 0.140 |
Why?
| | Medicare | 1 | 2022 | 661 | 0.140 |
Why?
| | Adolescent | 3 | 2021 | 17724 | 0.140 |
Why?
| | Adult | 5 | 2023 | 30245 | 0.130 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 4593 | 0.120 |
Why?
| | Electrolytes | 1 | 2015 | 52 | 0.120 |
Why?
| | Nutritionists | 1 | 2014 | 13 | 0.120 |
Why?
| | Soybean Oil | 1 | 2014 | 12 | 0.120 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 133 | 0.120 |
Why?
| | Societies, Medical | 1 | 2018 | 654 | 0.120 |
Why?
| | Academies and Institutes | 1 | 2014 | 44 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4400 | 0.110 |
Why?
| | Vitamins | 1 | 2015 | 150 | 0.110 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2015 | 133 | 0.110 |
Why?
| | Parents | 1 | 2020 | 1175 | 0.100 |
Why?
| | Curriculum | 1 | 2018 | 803 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 581 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1465 | 0.100 |
Why?
| | Clinical Competence | 1 | 2018 | 882 | 0.100 |
Why?
| | Amino Acids | 1 | 2015 | 443 | 0.090 |
Why?
| | Young Adult | 2 | 2019 | 10400 | 0.090 |
Why?
| | Infant, Premature, Diseases | 1 | 2012 | 88 | 0.090 |
Why?
| | Nutritional Status | 2 | 2023 | 286 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2014 | 9006 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1080 | 0.090 |
Why?
| | Survival Analysis | 1 | 2013 | 1203 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1822 | 0.090 |
Why?
| | Glucose | 1 | 2015 | 894 | 0.090 |
Why?
| | Quality of Life | 1 | 2020 | 2335 | 0.080 |
Why?
| | Logistic Models | 1 | 2014 | 1832 | 0.080 |
Why?
| | Infant, Premature | 1 | 2012 | 479 | 0.080 |
Why?
| | Child Welfare | 1 | 2010 | 190 | 0.080 |
Why?
| | Critical Illness | 1 | 2013 | 653 | 0.080 |
Why?
| | Heparin | 1 | 2009 | 225 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2015 | 12504 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2310 | 0.070 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1378 | 0.070 |
Why?
| | Risk Assessment | 1 | 2015 | 2953 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 922 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1630 | 0.060 |
Why?
| | Societies | 1 | 2023 | 36 | 0.060 |
Why?
| | Age Factors | 1 | 2010 | 2875 | 0.050 |
Why?
| | Algorithms | 1 | 2010 | 1462 | 0.050 |
Why?
| | Prospective Studies | 1 | 2014 | 6189 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6296 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2023 | 75 | 0.050 |
Why?
| | Fenfluramine | 1 | 2022 | 13 | 0.050 |
Why?
| | Drug Storage | 1 | 2022 | 57 | 0.050 |
Why?
| | Drug Stability | 1 | 2022 | 149 | 0.050 |
Why?
| | Epileptic Syndromes | 1 | 2022 | 66 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2022 | 172 | 0.050 |
Why?
| | Aged | 2 | 2022 | 18944 | 0.050 |
Why?
| | Spasms, Infantile | 1 | 2022 | 103 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2022 | 176 | 0.040 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 40 | 0.040 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 163 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2021 | 149 | 0.040 |
Why?
| | Temperature | 1 | 2022 | 557 | 0.040 |
Why?
| | Seizures | 1 | 2022 | 335 | 0.040 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 118 | 0.040 |
Why?
| | Research | 1 | 2021 | 387 | 0.040 |
Why?
| | Health Care Costs | 1 | 2021 | 381 | 0.040 |
Why?
| | Work | 1 | 2017 | 17 | 0.040 |
Why?
| | Time Management | 1 | 2017 | 18 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 616 | 0.040 |
Why?
| | Precision Medicine | 1 | 2021 | 335 | 0.040 |
Why?
| | Patient Care Team | 1 | 2022 | 518 | 0.040 |
Why?
| | Occupational Stress | 1 | 2017 | 35 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 963 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 582 | 0.030 |
Why?
| | Intestinal Diseases | 1 | 2016 | 33 | 0.030 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 185 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1076 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2016 | 97 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 158 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 770 | 0.030 |
Why?
| | History, 20th Century | 1 | 2016 | 265 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2017 | 376 | 0.030 |
Why?
| | Pain | 1 | 2020 | 699 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 340 | 0.030 |
Why?
| | Middle Aged | 1 | 2013 | 26552 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 951 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2530 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1168 | 0.030 |
Why?
| | Colorado | 1 | 2020 | 4061 | 0.020 |
Why?
|
|
Blackmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|